共 129 条
[1]
Yusuf S(2001)Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 494-502
[2]
Zhao F(2002)Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2411-2420
[3]
Mehta SR(2005)Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 1179-1189
[4]
Chrolavicius S(2005)Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study JAMA 294 1224-1232
[5]
Tognoni G(2009)Variability in responsiveness to oral antiplatelet therapy Am J Cardiol 103 27A-34A
[6]
Fox KK(2009)Cytochrome p-450 polymorphisms and response to clopidogrel N Engl J Med 360 354-362
[7]
Steinhubl SR(2009)Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy JAMA 302 849-857
[8]
Berger PB(2009)Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study Lancet 373 309-317
[9]
Mann JT(2011)Clinical, angiographic, and genetic factors associated with ealy conrn ary stent thrombosis JAMA 306 1765-1774
[10]
Sabatine MS(2011)High doses of clopidogrel to overcome genetic resistance (the CLOVIS-2 study) JACC Cardiovasc Interv 4 392-402